Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
279.79B | 245.09B | 226.74B | 194.80B | 183.62B | Gross Profit |
128.74B | 110.86B | 100.30B | 88.60B | 82.81B | EBIT |
40.14B | 34.35B | 30.84B | 27.40B | 25.24B | EBITDA |
52.85B | 43.82B | 40.45B | 37.33B | 32.44B | Net Income Common Stockholders |
23.73B | 19.54B | 19.03B | 15.71B | 10.31B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
32.78B | 31.06B | 40.28B | 47.25B | 43.50B | Total Assets |
307.99B | 273.52B | 278.00B | 271.57B | 263.07B | Total Debt |
76.88B | 67.73B | 80.81B | 87.29B | 88.78B | Net Debt |
44.10B | 36.67B | 40.53B | 40.04B | 45.29B | Total Liabilities |
157.44B | 139.81B | 146.12B | 144.00B | 140.61B | Stockholders Equity |
143.43B | 127.03B | 125.38B | 121.55B | 116.87B |
Cash Flow | Free Cash Flow | |||
16.65B | 21.66B | 17.76B | 22.73B | 60.35B | Operating Cash Flow |
42.44B | 42.29B | 35.49B | 32.72B | 70.29B | Investing Cash Flow |
-23.39B | -20.07B | -19.60B | -9.55B | -21.02B | Financing Cash Flow |
-19.64B | -26.35B | -20.85B | -20.26B | 834.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $306.80B | 28.57 | 40.98% | 2.71% | 1.08% | 0.28% | |
79 Outperform | $41.26B | 26.85 | 17.43% | 2.35% | 11.73% | -15.34% | |
74 Outperform | $46.23B | 30.83 | 6.13% | 2.62% | 3.95% | -28.73% | |
74 Outperform | $4.95B | 15.83 | 17.12% | 3.10% | 1.54% | 4.48% | |
73 Outperform | $10.40B | 18.98 | 44.38% | 0.44% | 3.69% | 60.51% | |
66 Neutral | $12.51B | 20.07 | -3.43% | 1.13% | 29.32% | -100.27% | |
64 Neutral | $8.82B | 14.87 | 4.61% | 174.99% | 3.74% | 5.11% |